Chuikyo to Discuss Out-of-Cycle Re-Pricing for Opdivo, but JMA Turns Wary

July 28, 2016
JMA Vice President Toshio Nakagawa (center) at Chuikyo General Meeting The health ministry’s Central Social Insurance Medical Council on July 27 agreed to discuss a special measure to cut the reimbursement prices of Opdivo (nivolumab), including its possible ad-hoc re-pricing...read more